Prothena Corporation plc (NASDAQ: PRTA) Stock: Will It Keep Climbing Higher?

In the last trading session, 9.64 million shares of the Prothena Corporation plc (NASDAQ:PRTA) were traded, and its beta was 0.05. Most recently the company’s share price was $4.58, and it changed around -$2.0 or -30.40% from the last close, which brings the market valuation of the company to $246.53M. PRTA currently trades at a discount to its 52-week high of $25.42, offering almost -455.02% off that amount. The share price’s 52-week low was $6.36, which indicates that the current value has fallen by an impressive -38.86% since then.

Prothena Corporation plc stock received a consensus recommendation rating of Buy, based on a mean score of 2.11. If we narrow it down even further, the data shows that 0 out of 11 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 3 recommended PRTA as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight.

Prothena Corporation plc (NASDAQ:PRTA) trade information

Instantly PRTA has showed a red trend with a performance of -30.40% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 7.59 on recent trading dayincreased the stock’s daily price by 39.66%. The company’s shares are currently down -66.93% year-to-date, but still down -38.11% over the last five days. On the other hand, Prothena Corporation plc (NASDAQ:PRTA) is -52.78% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $56, which translates to bulls needing to increase their stock price by 91.82% from its current value. Analyst projections state that PRTA is forecast to be at a low of $24 and a high of $98.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -3.15%. Prothena Corporation plc earnings are expected to increase by -60.06% in 2025, but the outlook is negative -15.31% per year for the next five years.

PRTA Dividends

Prothena Corporation plc’s next quarterly earnings report is expected to be released in June.

FMR LLC, with 15.0012% or 8.07 million shares worth $166.48 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund were the top two Mutual Funds as of Jan 31, 2025 . The former held 4.22 shares worth $19.33 million, making up 7.84% of all outstanding shares. On the other hand, Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund held roughly 2.32 shares worth around $10.62 million, which represents about 4.31% of the total shares outstanding.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.